Sinonasal Inflammatory Myofibroblastic Tumor with Anaplastic Lymphoma Kinase 1 Rearrangement: Case Study and Literature Review

Head Neck Pathol. 2017 Jun;11(2):131-138. doi: 10.1007/s12105-016-0744-3. Epub 2016 Jul 21.

Abstract

Inflammatory myofibroblastic tumors (IMTs) are rare mesenchymal tumors initially described in the lung. About half of them exhibit expression of the ALK1 protein, generally resulting from a gene rearrangement. Paranasal sinus IMTs are extremely uncommon, and gene rearrangement of ALK1 is very rare in this localization. A 47-year-old woman presented with rapidly progressive vision loss in her left eye. Clinical and imaging work-up revealed a tumor invading the left ethmoidal and sphenoidal sinuses and extending into the nasal cavity, the orbit and the skull base. Complete tumor resection was performed using an endonasal approach. Pathological examination revealed a paranasal localization of IMT, positive for ALK1 immunostaining. FISH analysis showed an ALK1 gene rearrangement. This case illustrates the local aggressive potential for IMTs. Treatment is primarily surgical, but targeted therapies (crizotinib) might be a solution for ALK1 rearranged cases with a poor prognosis.

Keywords: Anaplastic Lymphoma Kinase 1; Endoscopic approach; Inflammatory myofibroblastic tumor; Sinonasal tumor; Targeted therapies.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Activin Receptors, Type II / genetics*
  • Female
  • Gene Rearrangement
  • Humans
  • Middle Aged
  • Paranasal Sinus Neoplasms / genetics*
  • Paranasal Sinus Neoplasms / pathology
  • Soft Tissue Neoplasms / genetics*
  • Soft Tissue Neoplasms / pathology

Substances

  • ACVRL1 protein, human
  • Activin Receptors, Type II